This transition, coupled with an associated reduction in workforce of approximately 55% and reductions in operating expenses, is expected to extend cash runway into the first quarter of 2027.
All entries for: Passage Bio
January 10, 2025
Passage Bio
Layoffs
Philadelphia, PA
51-200 employees
Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule